Alcidion Group Limited · ASX:ALC
Alcidion — H1 FY2024 Earnings Presentation
29 slides from Alcidion's earnings presentation, Feb 28, 2024
Slide 1: H1 FY24 Results Presentation
H1 FY24 Results Presentation 28 February 2024
Slide 2: Smarter, Modular, Cloud Native
SMARTER Alcidion Group Limited (ASX: ALC) was founded with one simple belief: MODULAR Smart technology can drive meaningful change CLOUD NATIVE Alcidion is delivering smarter solutions for clinicians and enabling our clients to harness the power of their data. Alcidion’s platform, Miya Precision, de
Slide 3: Alcidion – a snapshot
Alcidion – a snapshot Healthcare software and informatics company providing an innovative technology platform to improve the efficiency and quality of patient care 40 Clients UK Aggregate and analyse data, using AI to enable a proactive (rather than 132 Hospitals reactive) approach to patient care 4
Slide 4: Miya Precision…making it easier for clinicians
Miya Precision…making it easier for clinicians • Device Agnostic – new generation of clinicians comfortable using mobile/tablet • Intuitive dashboards – easy to read while time poor and on the move • Clinical support – assisting clinicians with relevant tests and workflows given the patients present
Slide 5: Smarter Solutions for Clinicians
Smarter Solutions for Clinicians by Alcidion Powering Smarter Care At the core of Alcidion’s solutions is our Patient Virtual Operations Specialised FHIR-based interoperability platform for Flow Care Centre Care smarter decision support Industry leading Virtual care and Integrated Emergency digital
Slide 6: Enhancing our offering – product developments
Enhancing our offering – product developments Miya Emergency Miya Results Tracking Miya Command Future of Patient Administration Bridging Gaps in Comprehensive Results Region Wide Perspectives The Future of Patient Emergency Visibility Administration Designed from the ground up for Diagnostic result
Slide 7: H1 FY24 Highlights
H1 FY24 Highlights
Slide 8: H1 FY24 – Executive Summary
H1 FY24 – Executive Summary Revenue $19.1M $0.1M 1 H1’24 TCV2 new sales $24.3M 31% Gross Margin 87.8% 170 bps Sold Revenue for FY243 $35.5M 4% Future EBITDA ($2.9M) $1.7M Contracted Revenue (FY25-FY29) $126M Operating Cashflow ($11.4M) $6.5M Cash $7.9M ($6.7M) 1. Comparisons are to prior correspondi
Slide 9: H1 FY24 – Executive Summary (cont.)
H1 FY24 – Executive Summary (cont.) • South Tees NHS Trust UK): $23.3M contract extension ($20.5m incl. in new contracted sales) to 2033 for Miya Precision EPR. Further options to extend to 2038 + add new modules. Up to $54M TCV over the next 15 years New & • Hampshire Hospitals (UK): Signed contrac
Slide 10: H1 FY24 Financials
H1 FY24 Financials
Slide 11: Profit & Loss
Profit & Loss Profit & loss ($000) H1'24 H1'23 % change Key Comments Recurring revenue 14,045 13,856 1% Non-recurring revenue 5,014 5,128 (2%) • H1’24 revenue of $19.1M, in-line with H1’23 Total revenue 19,059 18,984 0% Direct costs (2,322) (2,647) (12%) A$M Products Product Imp Services Total Gross
Slide 12: Revenue Dashboard
Revenue Dashboard 45.0 40.4 $M 40.0 34.4 35.0 30.0 21.4 25.9 25.0 21.5 Half-on- 20.0 16.9 18.6 14.8 half 15.0 10.4 9.6 revenue 10.0 19.0 19.1 5.0 11.1 12.9 7.3 8.2 - FY19 FY20 FY21 FY22 FY23 FY24 H1 H2 Geographical 42% $19.1M Split (H1’24) Total 100% 58% 90% (UK / ANZ) 32% 32% 26% 80% 37% 44% 70% 53
Slide 13: Our revenue model and breakdown
Our revenue model and breakdown… Licence fees + Maintenance & Support (M&S) recurring revenue will underpin future sustainable and increasingly profitable growth Products ~95%1 Technical Services ~5%1 Core Offering Key Product / Data analytics, Integration, Services interoperability & technical desi
Slide 14: Balance Sheet
Balance Sheet Balance sheet ($000) 31-Dec-23 30-Jun-23 Key Comments Cash & cash equivalents 7,914 14,641 Trade & other receivables 8,457 4,735 • $7.9M cash and no debt Other assets 1,279 1,602 Current assets 17,650 20,978 • Receivables include material debtor of $3.9M which was Plant & equipment 555
Slide 15: Cashflow
Cashflow Cash flow ($000) H1'24 H1'23 Key Comments Receipts from customers 15,105 18,819 Payments to suppliers & employees (26,505) (23,753) Income tax paid - - • H1’24 historically lower period for receipts aligning with various Interest received 30 43 customer billing cycles, particularly in the U
Slide 16: H1 FY24 Operations
H1 FY24 Operations
Slide 17: Notable Contract Wins and Renewals
Notable Contract Wins and Renewals New contracts reinforce modular strategy, catering to needs of customers as they enhance their digital maturity South Tees NHS Trust (UK): Hampshire Hospitals (UK): • Signed $23.3M contract extension for an • Signed contract for Miya Emergency module additional 8 y
Slide 18: Successful Deployments
Successful Deployments Product Implementation and technical services have always been a strength of the Alcidion business Hereford and Worcester NHS (UK) Te Whatu Ora Waikato (NZ): • First deployment of Miya Precision for Flow • Implemented Smartpage non-clinical to and Bed Management into community
Slide 19: Where we drive value
Where we drive value Customer reported benefit examples Emergency Department length Reduction in outliers 28.6% of stay reduction at admission* 17.7% (Triage cat 5)* Emergency Ways of working Department length 13-15% of stay reduction standardisation* 30 to 9 (Triage cat 1-4)* Nurse handover Alignme
Slide 20: South Tees Hospitals NHS Foundation Trust
South Tees Hospitals NHS Foundation Trust Middlesborough, United Kingdom Paperwork saved per patient per day when Miya Precision went live The adoption of a fully integration EPR system (less PAS) has delivered: Modular Implementation Approach >1HR 100% 15 TIME SAVED TRANSITION MINUTES › Acute servi
Slide 21: Market Position & Opportunity
Market Position & Opportunity
Slide 22: Our Solution…Miya Precision platform
Our Solution…Miya Precision platform Alcidion has built a smart platform for healthcare - Miya Precision, a cloud-native, modern, modular, open architecture platform taking on the major global incumbents Modern | Modular | Cloud native | Device agnostic | Clinician centric | Open Standards Patient S
Slide 23: Our sales strategy: Modular sales driving TCV uplift
Our sales strategy: Modular sales driving TCV uplift Miya Precision’s modular design supports a ‘land & expand’ strategy to support automation and digitalization in healthcare *For illustrative purposes only Ability over time to replicate full EPR contract value ($15m - $30m) via modular add-ons $30
Slide 24: Global expansion potential…
Global expansion potential… Current Operations Future Geographical Expansion Key Criteria: Australia & New United • Sizable market Zealand Kingdom • English speaking (reduced development spend) • Healthcare structure similar to UK / Australia • Access to digital healthcare data 51% FY23 Revenue Targ
Slide 25: Outlook
Outlook
Slide 26: Outlook
Outlook Re-aligned cost base enables delivery of long-term value proposition; $200M+ potential EPR contracts being tendered for currently Key Comments • $35.5M contracted & scheduled renewal revenue for FY24 (as of 31 Dec 2023, before any new sales) • Recognising continued procurement delays, will i
Slide 27: Investment Highlights
Investment Highlights • Large Addressable Market Strong Financial Profile Marquee Customers • 146 Acute UK NHS Trusts; ALC with foothold • ~74% recurring revenue, supported by • $31.7M over 5.5 years with Leidos (Aus) to in only ~27% multi-year contracts assist Australian Defence Force with health r
Slide 28: Disclaimer
Disclaimer The information contained in this document (“Document”) has been prepared by Alcidion Group Limited ACN 143 142 410 (referred to as “Alcidion” or “Company”). This Document is current as at the date of this Document and should be read in conjunction with other Alcidion periodic and continu
Slide 29: Slide 29